Journal of Cardiology
Elsevier BV · GB · ISSN 09145087
动向摘要
Publication volume rose while average citedness softened.
Field-weighted citation impact moved from 1.69 to 1.46. Expect slightly lower citation density per paper than before. Output grew sharply while citation impact fell. If you prioritise citations, weigh this trend when choosing a venue. Atrial Fibrillation Management and Outcomes rose from 10.0% to 15.6% of what the journal runs. If your work is on atrial fibrillation, visibility in the journal is improving. Recent titles increasingly carry selexipag · sacubitril · hfpef · impella · transthyretin. Consider this journal if your manuscript deals with those emerging clinical interventions.
引用指标
基于 Scopus 与 OpenAlex 引用图谱。本站不提供 Clarivate 的 JCR 影响因子。
发文量与被引表现
发文量增长时被引表现是否同步。
主题变化
对比近 24 个月(2024-09 – 2026-08)与此前 24 个月(2022-09 – 2024-08)的占比。
- Atrial Fibrillation Management and Outcomes10.0%→15.6%+5.6%p此前近期
- Heart Failure Treatment and Management7.9%→13.2%+5.3%p此前近期
- Congenital Heart Disease Studies0.0%→3.8%+3.8%p此前近期
- Transplantation: Methods and Outcomes0.0%→3.3%+3.3%p此前近期
- Acute Kidney Injury Research0.0%→2.8%+2.8%p此前近期
- Cardiac Valve Diseases and Treatments15.8%→9.9%−5.9%p此前近期
- Cardiac Imaging and Diagnostics8.9%→4.3%−4.7%p此前近期
- Cardiac Arrest and Resuscitation3.2%→0.0%−3.2%p此前近期
- Cardiac Arrhythmias and Treatments3.2%→0.0%−3.2%p此前近期
- Cardiac pacing and defibrillation studies5.3%→2.4%−2.9%p此前近期
近期高频术语
近期论文标题中相较以往显著增加的表述。
作者国家构成
将近 24 个月(2024-09 – 2026-08)与此前 24 个月(2022-09 – 2024-08)并列显示。
- JP68.4%→57.2%−11.2%p此前近期
- US19.1%→15.3%−3.8%p此前近期
- CN2.6%→11.8%+9.2%p此前近期
- PK0.0%→4.0%+4.0%p此前近期
- GB2.0%→3.8%+1.8%p此前近期
- IT0.0%→3.2%+3.2%p此前近期
机构发文 Top 5
2018 – 2026 期间在该期刊发表论文的前 5 家机构。
近期发表论文
20按发表日期最新的 20 篇,并非全部。
高被引论文
202018 – 2026 期间被引最高的 20 篇。
相似期刊
数据截至 2026-09-05